- Home
- Equipment
- north america
- carcinoma squamous
Refine by
Carcinoma Squamous Equipment Supplied In North America
68 equipment items found
Manufactured by:Creative BioMart based in, NEW YORK (USA)
Keratin 8 belongs to the type B (basic) subfamily of high molecular weight keratins and exists in combination with keratin 18. Keratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
KP372-1 is also an NQO1 redox cycling agent that causes DNA damage (including DNA breakage) by generating ROS. KP372-1 can be used in cancer research (such as head and neck squamous cell carcinoma (HNSCC) and pancreatic cancer). ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
Bladder cancer is one of the most common types of cancer which like lung and other cancers, is quite heterogeneous. Bladder cancer occurs more frequently in men than women, generally at an older age, and is more common among smokers than non-smokers. The most common type of bladder cancer begins within cells that line the inside of the bladder, urothelial cells – also called transitional ...
Manufactured by:EDM3 Solutions based inJacksonville, FLORIDA (USA)
Tissue staining is the cornerstone of Mohs Micrographic Surgery (MMS). EDM3s new “all inclusive” Mohs Lab Staining Kit, will consistently yield slides with the highest quality, excellent morphology and differentiation of target cellular components. The kit includes marking dyes, freezing medium, bleaching reagents, both Hematoxylin and Eosin (H&E) and Toluidine Blue (T-blue) ...
Manufactured by:AVITA Medical based inValencia, CALIFORNIA (USA)
Epidermolysis Bullosa (EB) is a group of rare and incurable skin disorders caused by mutations in genes encoding structural proteins resulting in skin fragility and blistering, leading to chronic wounds and, in some sub-types, an increased risk of squamous cell carcinoma or death. Dystrophic EB is estimated to affect 3-8 million people[1], and there is currently ...
by:Traws Pharma based inNewtown, PENNSYLVANIA (USA)
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but acts via allosteric inhibition. Rigosertib has the potential to affect three critical pathways for cancer cell proliferation and survival: the ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
Head and Neck Cancer, a group of cancers that starts within the mouth, nose, throat, larynx, sinuses, or salivary glands, is the seventh most common of all cancers. Because most majority begin in squamous cells which line the moist surfaces inside the head and neck areas, such cancers are also referred to as Head and Neck Squamous Cell Carcinomas ...
Manufactured by:Fujirebio based inMalvern, PENNSYLVANIA (USA)
CanChek Tumor Marker Control Serum is intended for use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma antigen (SCCA). The use of a quality control serum is indicated to verify the performance characteristics of an in vitro diagnostic laboratory test and ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling more informed choices about treatment and follow-up ...
Manufactured by:Xstrahl based inNorcross, GEORGIA (US) (USA)
The Xstrahl 150 is a low-energy X-ray system designed primarily for the treatment of non-melanoma skin cancers and various superficial skin conditions. It is particularly effective for types such as basal cell carcinoma and squamous cell carcinoma, as well as benign skin conditions, including keloid scars and hyperproliferative disorders like ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
Pancreatic Cancer is the 11th most common cancer type with an estimated 55,000 new cases in the US in 2018, according to the United States National Cancer Institute. While it represents three percent of all cancers, pancreatic cancer is one of the most lethal as it is so difficult to detect in early stages, accounting for seven percent of all cancer deaths and carrying among the lowest five ...
Manufactured by:Xstrahl based inNorcross, GEORGIA (US) (USA)
The Xstrahl 100 is a specialized low-energy X-ray system designed to provide accurate treatment for superficial skin conditions, including non-melanoma skin cancers like basal cell and squamous cell carcinomas, as well as benign skin conditions such as keloid scars. This system offers pinpoint accuracy to ensure that healthy skin remains unaffected during ...
Manufactured by:MiraDx based inLos Angeles, CALIFORNIA (USA)
Although it is completely logical that inherited, germ-line genetic differences, present in all cells, including those of the immune system, will predict response and toxicity to developing immune therapies, there has been little study of the genomic areas studied by MiraDx to find such biomarkers. MiraDx discovered a panel of such mutations that predict both response and toxicity to anti-PD1 and ...
by:Aegle Therapeutics based inWoburn, MASSACHUSETTS (USA)
Epidermolysis bullosa (“EB”) is a group of rare genetic disorders that manifests as blistering or erosion of the skin in response to little or no apparent trauma. There are many genetic and symptomatic variations of EB. EB is always painful, often pervasive and debilitating, and is in some cases lethal before the age of 30. EB affects both genders and every racial and ethnic ...
Manufactured by:Xstrahl based inNorcross, GEORGIA (US) (USA)
Radiant Aura supports the administration of superficial radiation therapy, offering an alternative to Mohs surgery for basal cell carcinoma and squamous cell carcinoma. The XBeam software integrated with the system facilitates protocol calculations and therapy planning, thus simplifying workflow and enhancing the efficiency of treatment delivery. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
UCL-TRO-1938 is a potent small molecule allosteric activator of PI3Kα with an EC50 value of approximately 60 μM. UCL-TRO-1938 can induce cell proliferation and has cardioprotective effects from ischaemia reperfusion injury and enhances nerve regeneration following nerve ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Namitecan is a potent topoisomerase I inhibitor, with antitumor ...